ResMed Income from Continuous Operations 2010-2025 | RMD
ResMed annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- ResMed income from continuous operations for the quarter ending March 31, 2025 was $0.365B, a 21.48% increase year-over-year.
- ResMed income from continuous operations for the twelve months ending March 31, 2025 was $1.313B, a 37.03% increase year-over-year.
- ResMed annual income from continuous operations for 2024 was $1.021B, a 13.75% increase from 2023.
- ResMed annual income from continuous operations for 2023 was $0.898B, a 15.15% increase from 2022.
- ResMed annual income from continuous operations for 2022 was $0.779B, a 64.26% increase from 2021.
| ResMed Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $1,021 |
| 2023 | $898 |
| 2022 | $779 |
| 2021 | $475 |
| 2020 | $622 |
| 2019 | $405 |
| 2018 | $316 |
| 2017 | $342 |
| 2016 | $352 |
| 2015 | $353 |
| 2014 | $345 |
| 2013 | $307 |
| 2012 | $255 |
| 2011 | $227 |
| 2010 | $190 |
| 2009 | $146 |
| ResMed Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $365 |
| 2024-12-31 | $345 |
| 2024-09-30 | $311 |
| 2024-06-30 | $292 |
| 2024-03-31 | $300 |
| 2023-12-31 | $209 |
| 2023-09-30 | $219 |
| 2023-06-30 | $230 |
| 2023-03-31 | $233 |
| 2022-12-31 | $225 |
| 2022-09-30 | $210 |
| 2022-06-30 | $195 |
| 2022-03-31 | $179 |
| 2021-12-31 | $202 |
| 2021-09-30 | $204 |
| 2021-06-30 | $195 |
| 2021-03-31 | $-78 |
| 2020-12-31 | $180 |
| 2020-09-30 | $178 |
| 2020-06-30 | $178 |
| 2020-03-31 | $163 |
| 2019-12-31 | $161 |
| 2019-09-30 | $120 |
| 2019-06-30 | $69 |
| 2019-03-31 | $105 |
| 2018-12-31 | $125 |
| 2018-09-30 | $106 |
| 2018-06-30 | $110 |
| 2018-03-31 | $110 |
| 2017-12-31 | $10 |
| 2017-09-30 | $86 |
| 2017-06-30 | $102 |
| 2017-03-31 | $88 |
| 2016-12-31 | $77 |
| 2016-09-30 | $76 |
| 2016-06-30 | $83 |
| 2016-03-31 | $91 |
| 2015-12-31 | $96 |
| 2015-09-30 | $83 |
| 2015-06-30 | $87 |
| 2015-03-31 | $91 |
| 2014-12-31 | $91 |
| 2014-09-30 | $83 |
| 2014-06-30 | $88 |
| 2014-03-31 | $90 |
| 2013-12-31 | $87 |
| 2013-09-30 | $81 |
| 2013-06-30 | $73 |
| 2013-03-31 | $85 |
| 2012-12-31 | $78 |
| 2012-09-30 | $71 |
| 2012-06-30 | $77 |
| 2012-03-31 | $65 |
| 2011-12-31 | $63 |
| 2011-09-30 | $51 |
| 2011-06-30 | $58 |
| 2011-03-31 | $53 |
| 2010-12-31 | $58 |
| 2010-09-30 | $57 |
| 2010-06-30 | $53 |
| 2010-03-31 | $49 |
| 2009-12-31 | $46 |
| 2009-09-30 | $42 |
| 2009-06-30 | $45 |
| 2009-03-31 | $39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.623B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
| Boston Scientific (BSX) | United States | $151.510B | 37.93 |
| Stryker (SYK) | United States | $148.668B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
| Medtronic (MDT) | Ireland | $113.608B | 16.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
| Agilent Technologies (A) | United States | $34.375B | 22.41 |
| Terumo (TRUMY) | Japan | $24.785B | 32.19 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $20.867B | 81.91 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
| Baxter (BAX) | United States | $15.734B | 11.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.038B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
| Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
| Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
| Haemonetics (HAE) | United States | $3.650B | 16.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.415B | 28.38 |
| ICU Medical (ICUI) | United States | $3.262B | 24.05 |
| QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
| LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| Acuren (TIC) | United States | $1.379B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
| Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
| Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
| Neogen (NEOG) | United States | $1.137B | 14.56 |
| BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
| InMode (INMD) | Israel | $0.971B | 9.78 |
| Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Owens & Minor (OMI) | United States | $0.695B | 5.76 |
| Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Evolus (EOLS) | United States | $0.597B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| SNDL (SNDL) | Canada | $0.363B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Quanterix (QTRX) | United States | $0.327B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
| Cerus (CERS) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.268B | 12.19 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
| Brainsway (BWAY) | Israel | $0.243B | 64.35 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.47 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Jin Medical (ZJYL) | China | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.57 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |